Trials / Unknown
UnknownNCT06564363
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma: a Single Center Prospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 148 (estimated)
- Sponsor
- Wuhan Ammunition Life-tech Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The clinical trial was designed to determine the efficacy (sensitivity and specificity) of the IUrisure test compared to the gold standard cystoscopy and pathology in patients under monitoring for recurrence of urothelial carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | IUrisure test | Postoperative patients are followed up every three months on average, and IUrisure test was performed at each follow-up visit. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-09-30
- Completion
- 2025-12-31
- First posted
- 2024-08-21
- Last updated
- 2024-08-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06564363. Inclusion in this directory is not an endorsement.